Patents by Inventor Michael David FORREST

Michael David FORREST has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250057851
    Abstract: Compounds that slow the ATP-hydrolysing mode of ATP synthase are useful for treating various diseases and disorders including cancer, particularly cancers that utilise the Warburg effect.
    Type: Application
    Filed: August 18, 2024
    Publication date: February 20, 2025
    Inventor: Michael David Forrest
  • Publication number: 20240392383
    Abstract: Biomarkers of cancer susceptibility/resistance to almitrine treatment are disclosed.
    Type: Application
    Filed: September 22, 2021
    Publication date: November 28, 2024
    Inventor: Michael David Forrest
  • Publication number: 20230142073
    Abstract: Hypoxemia is an abnormally low O2 concentration in the blood. It can be lethal. When vital organs don't get enough O2 to operate properly. A coronavirus infection can cause hypoxemia. Wherein this is probably the most common cause of coronavirus associated death. COVID-19 has killed millions of people to date. A method comprising the administration of a therapeutically effective amount of almitrine dimesylate to a subject with a coronavirus infection. To treat/ameliorate/reduce/prevent any coronavirus associated hypoxemia in the subject. Therein increasing the subject's chance of survival.
    Type: Application
    Filed: March 15, 2021
    Publication date: May 11, 2023
    Inventor: Michael David Forrest
  • Publication number: 20200306253
    Abstract: Compounds of the following formula (I) slow the ATP-hydrolysing mode of ATP synthase and are useful for treating various diseases and disorders including cancer, particularly cancers that utilise the Warburg effect.
    Type: Application
    Filed: July 13, 2018
    Publication date: October 1, 2020
    Inventor: Michael David Forrest
  • Publication number: 20200247758
    Abstract: Compounds of the following formula, and pharmaceutically-acceptable salts, solvates, hydrates and prodrugs thereof, formula (A) are useful to preferentially inhibit the ATP-hydrolysing mode of ATP synthase, and are thereby useful for treating various diseases and orders including cancer, particularly cancers that utilise the Warburg effect.
    Type: Application
    Filed: January 17, 2018
    Publication date: August 6, 2020
    Inventor: Michael David FORREST